Drug Profile
Anti-CD16-anti-CD30 monoclonal antibody
Alternative Names: Anti-CD16-anti-CD30 bispecific monoclonal antibody; Anti-CD30-anti-CD16 bispecific monoclonal antibody; Anti-CD30-anti-CD16 monoclonal antibodyLatest Information Update: 27 Apr 2022
Price :
$50
*
At a glance
- Originator Biotest
- Class Antineoplastics; Bispecific antibodies; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Lymphocyte stimulants; Natural killer cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hodgkin's disease